These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28081046)

  • 1. Evaluation of Herpes Simplex Virus Type 2 Serological Tests for Use With Dried Blood Spots in Kenya.
    Hobbs MM; Mwanyumba SW; Luseno WK; Hartman S; Halpern CT; Hallfors DD; Cho H
    Sex Transm Dis; 2017 Feb; 44(2):101-103. PubMed ID: 28081046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing.
    Smith JS; Bailey RC; Westreich DJ; Maclean I; Agot K; Ndinya-Achola JO; Hogrefe W; Morrow RA; Moses S
    Sex Transm Infect; 2009 Apr; 85(2):92-6. PubMed ID: 18955387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the HerpeSelect (Focus) and Kalon enzyme-linked immunosorbent assays for detection of antibodies against herpes simplex virus type 2 by use of monoclonal antibody-blocking enzyme immunoassay and clinicovirological reference standards in Brazil.
    Nascimento MC; Ferreira S; Sabino E; Hamilton I; Parry J; Pannuti CS; Mayaud P
    J Clin Microbiol; 2007 Jul; 45(7):2309-11. PubMed ID: 17507516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of a fragment of glycoprotein G of herpes simplex virus type 2 and evaluation of its diagnostic potential.
    Liu T; Liu JF; Yu H; Si GJ; Hu J; Li J
    Singapore Med J; 2015 Jun; 56(6):346-52. PubMed ID: 25532518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal blocking EIA for herpes simplex virus type 2 antibody: validation for seroepidemiological studies in Africa.
    Gopal R; Gibbs T; Slomka MJ; Whitworth J; Carpenter LM; Vyse A; Brown DW
    J Virol Methods; 2000 Jun; 87(1-2):71-80. PubMed ID: 10856754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans.
    Lingappa J; Nakku-Joloba E; Magaret A; Friedrich D; Dragavon J; Kambugu F; Joloba M; Whalen C; Coombs R; Celum C; Morrow RA
    Int J STD AIDS; 2010 Sep; 21(9):611-6. PubMed ID: 21097732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative performance of a novel herpes simplex virus type 2-specific enzyme-linked immunosorbent assay using a targeted chain oligopeptide, peptide 55.
    Al-Sulaiman AM; Vallely PJ; Klapper PE
    Clin Vaccine Immunol; 2009 Jun; 16(6):931-4. PubMed ID: 19369475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a novel serology algorithm to detect herpes simplex virus 1 or 2 antibodies.
    Zahariadis G; Severini A
    Sex Transm Dis; 2010 Nov; 37(11):696-9. PubMed ID: 20693937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection.
    Wald A; Ashley-Morrow R
    Clin Infect Dis; 2002 Oct; 35(Suppl 2):S173-82. PubMed ID: 12353203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of three multiplex flow immunoassays compared to an enzyme immunoassay for the detection and differentiation of IgG class antibodies to herpes simplex virus types 1 and 2.
    Binnicker MJ; Jespersen DJ; Harring JA
    Clin Vaccine Immunol; 2010 Feb; 17(2):253-7. PubMed ID: 20007366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.
    Delany-Moretlwe S; Jentsch U; Weiss H; Moyes J; Ashley-Morrow R; Stevens W; Mayaud P
    Sex Transm Infect; 2010 Feb; 86(1):46-50. PubMed ID: 19837726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the focus and Kalon enzyme-linked immunosorbent assays for antibodies to herpes simplex virus type 2 glycoprotein G in culture-documented cases of genital herpes.
    Morrow RA; Friedrich D; Krantz E
    J Clin Microbiol; 2003 Nov; 41(11):5212-4. PubMed ID: 14605166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical uses of herpes simplex virus type-specific serology.
    Munday PE; Mullan HM
    Int J STD AIDS; 2001 Dec; 12(12):784-8. PubMed ID: 11779367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of HSV-2 type specific serological tests in men in Kenya.
    Ng'ayo MO; Friedrich D; Holmes KK; Bukusi E; Morrow RA
    J Virol Methods; 2010 Feb; 163(2):276-81. PubMed ID: 19854222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Herpes simplex virus type 1 and 2].
    Yoshida M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():306-9. PubMed ID: 20942065
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition.
    Hogrefe W; Su X; Song J; Ashley R; Kong L
    J Clin Microbiol; 2002 Oct; 40(10):3635-40. PubMed ID: 12354858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of commercial enzyme immunoassays to detect antibodies to the herpes simplex virus type 2 glycoprotein G in a low-risk population in Hanoi, Vietnam.
    Ngo TD; Laeyendecker O; La H; Hogrefe W; Morrow RA; Quinn TC
    Clin Vaccine Immunol; 2008 Feb; 15(2):382-4. PubMed ID: 18077617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.
    Gamiel JL; Tobian AA; Laeyendecker OB; Reynolds SJ; Morrow RA; Serwadda D; Gray RH; Quinn TC
    Clin Vaccine Immunol; 2008 May; 15(5):888-90. PubMed ID: 18321879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance and use of HSV type-specific serology test kits.
    Ashley RL
    Herpes; 2002 Jul; 9(2):38-45. PubMed ID: 12106510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay.
    Wales SQ; Smith CC; Wachsman M; Calton G; Aurelian L
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):42-9. PubMed ID: 14715543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.